PTHS PELTHOS THERAPEUTICS INC Capital Structure Changes 8-K Filing 2024 - Stock Repurchase Plan Chromocell Therapeutics Corp authorized a stock repurchase plan to repurchase up to $250,000 of the company's common stock.Get access to all SEC 8-K filings of the PELTHOS THERAPEUTICS INC